Law360, Wilmington (July 6, 2016, 7:56 PM EDT) -- Artificial-heart-implant maker SynCardia Systems Inc. told a Delaware bankruptcy judge on Wednesday that it wants the company's sale to be completed by Aug. 22 and is preparing bid procedures for submission to the court by Aug. 1.
During a first-day hearing in Wilmington, attorneys for the debtor said a sale process that moves as swiftly as possible is in the best interests of the company, its creditors and the patients whose lives depend on its products. Selling the company to the highest bidder will ensure that first-lien creditors are paid and the total heart replacement implants already inserted into patients' bodies...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!